4.33
Compass Pathways Plc Adr stock is traded at $4.33, with a volume of 1.07M.
It is down -0.92% in the last 24 hours and up +56.88% over the past month.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
See More
Previous Close:
$4.37
Open:
$4.35
24h Volume:
1.07M
Relative Volume:
0.43
Market Cap:
$405.12M
Revenue:
-
Net Income/Loss:
$-144.32M
P/E Ratio:
-1.9862
EPS:
-2.18
Net Cash Flow:
$-105.21M
1W Performance:
+0.70%
1M Performance:
+56.88%
6M Performance:
+11.31%
1Y Performance:
-41.96%
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc Adr
Sector
Industry
Phone
1-716-676-6461
Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CMPS
Compass Pathways Plc Adr
|
4.33 | 408.86M | 0 | -144.32M | -105.21M | -2.18 |
![]()
HCA
Hca Healthcare Inc
|
334.32 | 82.15B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
26.43 | 15.70B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
THC
Tenet Healthcare Corp
|
153.02 | 13.78B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
DVA
Davita Inc
|
145.17 | 10.94B | 12.82B | 936.34M | 1.47B | 10.74 |
![]()
EHC
Encompass Health Corp
|
107.67 | 10.80B | 5.51B | 494.70M | 386.40M | 4.84 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-23-25 | Downgrade | Evercore ISI | Outperform → In-line |
Feb-27-25 | Initiated | Stifel | Buy |
Jul-23-24 | Initiated | RBC Capital Mkts | Outperform |
Apr-01-24 | Initiated | Morgan Stanley | Overweight |
Dec-12-23 | Initiated | Deutsche Bank | Buy |
Nov-21-22 | Resumed | Berenberg | Buy |
Nov-01-22 | Initiated | Loop Capital | Buy |
Oct-29-21 | Initiated | Oppenheimer | Outperform |
Jul-13-21 | Initiated | Citigroup | Buy |
Jun-28-21 | Initiated | Maxim Group | Buy |
May-11-21 | Initiated | Cantor Fitzgerald | Overweight |
Apr-01-21 | Initiated | ROTH Capital | Buy |
Oct-14-20 | Initiated | H.C. Wainwright | Buy |
Oct-13-20 | Initiated | Berenberg | Buy |
Oct-13-20 | Initiated | Canaccord Genuity | Buy |
Oct-13-20 | Initiated | Cowen | Outperform |
Oct-13-20 | Initiated | Evercore ISI | Outperform |
View All
Compass Pathways Plc Adr Stock (CMPS) Latest News
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped On Trial Results. Should You Buy The Dip? - Barchart.com
COMPASS Pathways (NASDAQ:CMPS) Receives “In-Line” Rating from Evercore ISI - Defense World
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts By Stocktwits - Investing.com India
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - MSN
Market Highlights: Compass Pathways Plc ADR (CMPS) Ends on a Low Note at 4.04 - DWinneX
Compass Pathways Plc ADR (CMPS) stock: A year of ups and downs - uspostnews.com
Investor’s Delight: Compass Pathways Plc ADR (CMPS) Closes Strong at 3.98, Up 5.57 - DWinneX
Should You Expect Compass Pathways Plc ADR (NASDAQ:CMPS) To Recover From Its 37.44% Gain From Highs? - Marketing Sentinel
CMPS Shares Experience Surge in Value - knoxdaily.com
Why Compass Pathways Stock Was a Double-Digit Winner This Week - The Motley Fool
Financial Snapshot: Analyzing Oil States International, Inc (OIS)’s Key Ratio Metrics - DWinneX
There is no doubt that Compass Pathways Plc ADR (CMPS) ticks all the boxes. - Sete News
ROKU (Roku Inc) may reap gains as insiders became active recently - knoxdaily.com
Taking a Closer Look At Compass Pathways Plc ADR (CMPS) Following Its Recent Trade - knoxdaily.com
Will Compass Pathways Plc ADR (CMPS) meet earnings estimates this quarter? - uspostnews.com
Compass Pathways Plc ADR (CMPS) Shares Are Down -5.56% YTD - Marketing Sentinel
Are Pebblebrook Hotel Trust’shares a good deal? - uspostnews.com
Trupanion Inc (TRUP) deserves closer scrutiny - uspostnews.com
CMPS’s Market Whiplash: -10.58% YTD Decline, 14.00% Rise in 30 Days - investchronicle.com
Compass Pathways appoints new US accounting firm By Investing.com - Investing.com South Africa
Compass Pathways appoints new US accounting firm - Investing.com
Netapp Inc (NTAP) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Compass Pathways Plc ADR (NASDAQ: CMPS) Could Slash -707.02% Soon - stocksregister.com
Taking a Closer Look At Cipher Mining Inc (CIFR) Following Its Recent Trade - knoxdaily.com
An In-Depth Look at Larimar Therapeutics Inc Inc. (LRMR) Price Performance During Market Crashes - investchronicle.com
West Pharmaceutical Services, Inc (WST) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Compass Pathways stock hits 52-week low at $2.87 By Investing.com - Investing.com South Africa
Compass Pathways stock hits 52-week low at $2.87 - Investing.com
Cantor Fitzgerald maintains Overweight on Compass Pathways stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Overweight on Compass Pathways stock - Investing.com India
Compass Pathways stock hits 52-week low at $3.15 By Investing.com - Investing.com South Africa
Compass Pathways stock hits 52-week low at $3.15 - Investing.com India
What Do Wall Street Analysts Think About Compass Pathways Plc ADR (NASDAQ: CMPS) Stock? - Stocks Register
Pinnacle Financial Partners Inc (PNFP) may enjoy gains as insiders got busy in the recent days - Knox Daily
MASS’s Q2 earnings estimates: What investors need to know - uspostnews.com
Compass Pathways shares surge on cash runway expectations - Investing.com
Compass Pathways shares surge on cash runway expectations By Investing.com - Investing.com UK
Earnings call transcript: Compass Pathways Q4 2024 sees stock rise amid stable EPS - Investing.com
Market Watch Highlights: Himax Technologies ADR (HIMX) Ends on an Downturn Note at 9.53 - The Dwinnex
Li-Cycle Holdings Corp (LICY)’s Day in Review: Closing at 0.85, Down by -2.72 - The Dwinnex
Compass Pathways Plc Adr Stock (CMPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):